CHIO3 Trial · CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Results posted: Sep 23, 2026
Also in this update: Primary completion date changed from estimate of Jul 2026 to Feb 24, 2025; Study completion pushed from Jul 2026 to Jul 2027
Alliance Foundation Trials, LLC.Phase 2 NCT04062708 Registry history of NCT04062708 on ClinicalTrials.gov (opens the registry)